Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1996-03-29
1998-07-07
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
424428, 546152, 546153, 546134, 546164, A61F 200, C07D21500, C07D21536, C07D21516
Patent
active
057764824
ABSTRACT:
Tetrahydroquinoline analogues and compositions containing them for topically treating glaucoma to effectively reduce intraocular eye pressure.
REFERENCES:
patent: 4260764 (1981-04-01), Johnson
patent: 4273775 (1981-06-01), Sarges
patent: 4309432 (1982-01-01), Tanaka et al.
patent: 4309545 (1982-01-01), Johnson
patent: 4322425 (1982-03-01), Yabuuchi et al.
patent: 4340737 (1982-07-01), Johnson
patent: 4555513 (1985-11-01), Hamada et al.
patent: 4678793 (1987-07-01), Klaus et al.
patent: 4738851 (1988-04-01), Schoenwald et al.
patent: 4798830 (1989-01-01), Lasslo et al.
patent: 4801593 (1989-01-01), Hodson et al.
patent: 4808619 (1989-02-01), Evans et al.
patent: 4843082 (1989-06-01), Biller et al.
patent: 4855291 (1989-08-01), Davies
patent: 4952573 (1990-08-01), LeClerc et al.
patent: 5219851 (1993-06-01), Hamilton et al.
patent: 5281600 (1994-01-01), Kojima et al.
patent: 5322859 (1994-06-01), Schoenwald et al.
patent: 5371226 (1994-12-01), Mederski et al.
patent: 5382576 (1995-01-01), Schoenwald et al.
patent: 5384318 (1995-01-01), Eggler et al.
patent: 5416095 (1995-05-01), Hanson et al.
patent: 5461063 (1995-10-01), Kelleher et al.
J.V. Braun, Chem. Ber. v. 42, pp. 2219-2227 (1909).
Prunte et al. "Topical SDZ GLC-756, A Novel Dopamine D-1 Antagonist and D-2 Agonist, Lowers Intraocular Pressure in Conscious Rabbits". Jpn. J. Ophthalmol., vol. 40, pp. 167-173, 1996.
Barfknecht Charles F.
Schoenwald Ronald D.
Knode Marian C.
Lee Datquan
University of Iowa Research Foundation
LandOfFree
Tetrahydroquinoline analogues for use in glaucoma treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetrahydroquinoline analogues for use in glaucoma treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydroquinoline analogues for use in glaucoma treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1202700